Gordon Carmichael, Ph.D.
DirectoratGyre Therapeutics· In proxies 2023–2025
Gordon Carmichael, Ph.D. sits on 1 public board.
Experience
- Gyre TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +49%
- Business Combination AgreementPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?